Filing Flows › 60 Degrees Pharmaceuticals (SXTP) › Q1 2026 › vs Q1 2025
60 Degrees Pharmaceuticals (SXTP) Q1 2026 vs Q1 2025 (year over year)
60 Degrees Pharmaceuticals's revenue fell $1K (-0.9%) from $164K in Q1 2025 to $162K in Q1 2026.
60 Degrees Pharmaceuticals, Q1 2026: revenue $162K (-0.9% year over year), net loss $2.1M, operating cash flow −$2.7M. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $162K | $164K | −$1K | -0.9% |
| Other income, net | $5K | $34K | −$29K | -86% |
| Net loss | $2.1M | $1.9M | $213K | +11% |
| Costs & expenses | $2.3M | $2.1M | $183K | +9% |
| Operating costs | $2.3M | $2.1M | $183K | +9% |
| Cost of revenue | $86K | $73K | $12K | +17% |
| Operating cash sources | $2.9M | $1.8M | $1.1M | +61% |
| Depreciation & amortization | $26K | $17K | $9K | +54% |
| Share-based compensation | $124K | $187K | −$63K | -34% |
| Cash used in operations | $2.7M | $1.6M | $1.1M | +72% |
| Net loss absorbed | $2.1M | $1.9M | $213K | +11% |
| Working capital & other | $801K | −$76K | $878K | — |
Questions
How much did 60 Degrees Pharmaceuticals's revenue grow year over year in Q1 2026?
60 Degrees Pharmaceuticals's revenue fell $1K (-0.9%) from $164K in Q1 2025 to $162K in Q1 2026.